| Name | Title | Contact Details |
|---|
CVRx® is a private company located in Minneapolis, Minnesota. The company has developed proprietary active implantable technology for the treatment of high blood pressure, also referred to as hypertension, and heart failure. The CVRx senior management and technical team have many years of experience commercializing implantable medical devices. The company is supported by an outstanding board of directors and a world-class scientific advisory board, which includes thought leading physicians and scientists in the field of hypertension and heart failure. CVRx has developed an implantable device that is designed to treat high blood pressure and heart failure. This new device called Barostim neo™ is designed to trigger the body`s own natural blood flow regulation system to treat high blood pressure and heart failure. CVRx has a strong intellectual property foundation, which will protect this unique technology. Barostim neo is CE marked in Europe for the treatment of hypertension patients. It is also CE marked in Europe for the treatment of heart failure. This product is currently under clinical evaluation in the United States and Canada for the treatment of high blood pressure and heart failure.
HomeCare Connect is a privately held company with a single-minded mission. We strive to provide the highest quality and most responsive home care services for our clients, which are workers’ compensation and auto liability insurance companies, employers and other payers. Based in the Orlando, Florida area, we serve clients nationally with a comprehensive range of home health care services, durable medical equipment and medical supplies. We have a clinically driven model — from our 15,000+ credentialed provider network to our highly experienced clinical staff who coordinate everything related to care, medical supplies and equipment delivered in the home. We make sure the injured worker receives the right care, equipment and supplies from the right providers at the right time.
Pentax Vision is a Hopkins, MN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
In 2015, five seminal randomized controlled trials were published in the neurovascular space demonstrating endovascular thrombectomy to be the new gold standard for treating large vessel occlusion strokes. During that same year, advancements in artificial intelligence and deep learning made it possible to analyze medical imaging rapidly and accurately. However, despite having proven effective interventions for stroke, most stroke patients were getting treatment late or not at all. At Stanford University, Dr. Chris Mansi (neurosurgeon) and Dr. David Golan (machine learning researcher) identified this problem and together they sought to change it.
BioVentrix is a privately held medical device company headquartered in San Ramon, CA, USA.